trial · primary record
Temozolomide monotherapy
Glioblastoma Multiforme
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 107 |
| Primary completion | 2032-06 |
| Primary endpoint | Overall survival |
| Registry ID | NCT04765514 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:51.811Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04765514
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.